According to Towards Healthcare study, the global in vitro diagnostics market size is calculated at USD 85.09 billion in 2025 and is expected to reach around USD 123.45 billion by 2034, growing at a ...

Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.

Backed by the European Innovation Council and driven by a 2030 vision of same-day diagnostics for all infectious diseases, Inbiome is advancing a future where rapid, precise pathogen detection curbs ...

Market Valued at US$ 24.85 Billion in 2023; Surging Demand for Precision Diagnostics and Aging Population Drive Steady Growth ...

Tecan Group (SIX Swiss Exchange: TECN) today announced an agreement to acquire certain assets relating to key ELISA ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

As the deadline for full application of the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) approaches, ...

A federal district court has struck a blow for medical innovation and patient empowerment by overruling the Food and Drug ...

The Asia Pacific in-vitro diagnostics (IVD) market, valued at USD 15.9 billion in 2023, is set to experience robust growth over the next decade, reaching USD 23.9 billion by 2032, according to new ...

Boditech Med Inc, a leading South Korean multinational diagnostics major, has inaugurated its plant at Model Economic ...

On March 31, a judge in the Eastern District of Texas vacated the US Food and Drug Administration’s (FDA) rule that sought to ...